Glucotrack, Inc. (GCTK)
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
GlucoTrack, Inc.
OTC:GCTKHealthcare · Medical - Devices
AHAfter hours+0.00%$0.4576
Prev close$0.4900-6.61%Close$0.45760.00%Now$0.4576
Close$0.4576-6.61%
Mkt Cap$542K
Float1.09M
O/S1.18M
VOL111K sh
$ Vol$47K
RVOL0.03×
Inst Own1.6%
SI6.7%
Dilution
Glucotrack, Inc. (GCTK) dilution facts from SEC filings
Snapshot as of Jun 30, 2026, built from 45 SEC filings.
- Shelf registration
- S-3 filed Jan 13, 2026, effective Jan 27, 2026 Source: 424B3 filed Jan 27, 2026
- At-the-market (ATM) program
- No active program in the filings reviewed
- Warrants outstanding
- 20 warrant series recorded as outstanding
- Most recent offering
- PIPE, closed Oct 22, 2026 Source: 8-K filed Oct 22, 2026
Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.